Bococizumab
Bococizumab
Bococizumab (pronounced boh-koh-siz-yoo-mab) is a monoclonal antibody designed for the treatment of hypercholesterolemia.
Etymology
The name "Bococizumab" is derived from the field of pharmacology. It follows the INN naming convention for monoclonal antibodies, where "-mab" is used as a suffix to denote the drug as a monoclonal antibody. The prefix "Boco-" does not have a specific meaning in this context.
Usage
Bococizumab is used in the treatment of hypercholesterolemia, a condition characterized by high levels of cholesterol in the blood. It works by inhibiting the action of PCSK9, a protein that regulates cholesterol levels in the body.
Related Terms
See Also
External links
- Medical encyclopedia article on Bococizumab
- Wikipedia's article - Bococizumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski